CClinicalTrials.gg
Status unknownNCT04238000Updated Jan 23, 2020

Cerebellar rTMS Theta Burst for Dual-task Walking in Parkinson's Disease

An interventional study of repetitive transcranial magnetic stimulation in Parkinson, Parkinson Disease and Gait Disorders, Neurologic, sponsored by Fondazione Europea di Ricerca Biomedica Ferb Onlus. Status unknown at 1 site in Italy. Open to participants aged 40 Years to 85 Years. Per ClinicalTrials.gov, last updated 2020-01-23.

Sponsored by Fondazione Europea di Ricerca Biomedica Ferb Onlus · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2020), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 2 years after the study started (first participant enrolled Jan 2018, registered Jan 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
40 Years to 85 Years
Sex
All
01

Study summary

Objective of the study:

To test the efficacy of theta burst cerebellar stimulation on dual task walking in Parkinson's disease using a cross-over design and wearing sensors technology

Design:

Twenty Parkinson's disease patients with no dementia will be recruited for a cross-over sham-controlled study. Each patient will undergo a sham stimulation or a single session of cerebellar theta burst stimulation with a wash out period of at least 14 days.

Each patient will be evaluated before and after stimulation by a battery of gait and movement tests using wearing sensors technology .

Read the detailed description

There are no medical effective treatments for dual-task gait in Parkinson's disease. Imaging, neurophysiology and pathology studies suggested cerebellum as possible target of brain stimulation for dual-task walking for theta Burst repetitive Transcranial magnetic stimulation

Objective of the study:

To test the efficacy of theta burst cerebellar stimulation on gait in Parkinson's disease using a cross-over design and wearing sensors technology

Design:

Parkinson's disease patients able to walk and without dementia/behavioral disturbances will be recruited for a cross-over sham-controlled study. Each patient will undergo a sham stimulation or a single session of cerebellar theta burst stimulation with a wash out period of at least 14 days.

Repetitive cerebellar theta burst stimulation will be performed by Duo-Mag XT100, using a 3 pulses at 50-Hz repeated at a rate of 5-Hz; 20 trains of 10 bursts given with 8-s intervals for a total of 600 pulses. Intensity of rTMS was set at the 80% of Amplitude of Motor Threshold (RMT) obtained in the left motor cortex for each subject.

A sample size of 20 subjects with complete stimulation (2 stimulations per subject, for a total number of stimulation)

Each patient will be evaluated before and after stimulation by a battery of gait and movement tests using wearing sensors technology.

Sensors assessment:

The following gait parameters will be evaluated in normal and cognitive/motor dual-tasks:

i) step length ii) step variability iii) step phases iv) turning speed

02

Conditions studied

  • Parkinson
  • Parkinson Disease
  • Gait Disorders, Neurologic
  • Parkinsonism
  • Gait, Festinating

Keywords

  • repetitive Transcranial Magnetic stimulation
  • rTMS
  • wearing sensors
  • wearables
  • step variability
  • gait variability
  • gait speed
  • dual-task
  • dual-task walking
  • turning
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's planned enrollment of 20 is below the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Fondazione Europea di Ricerca Biomedica Ferb Onlus is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • established Parkinson's disease
  • ability to stand alone and walk without support

Exclusion criteria

Exclusion Criteria:

  • dementia or behavioral alterations
  • contraindication to stimulation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
20 participants (estimated)

Study arms

  • Active comparator
    Real Stimulation

    Cerebellar Repetitive theta burst stimulation will be performed using a 3 pulses at 50-Hz repeated at a rate of 5-Hz; 20 trains of 10 bursts given with 8-s intervals for a total of 600 pulses. Intensity of rTMS was set at the 80% of Amplitude of Motor Threshold (RMT) obtained in the left motor cortex for each subject.

    Device: repetitive transcranial magnetic stimulation

  • Placebo comparator
    Sham Stimulation

    The rTMS coil stimulation will be applied in the same position of the real stimulation. The Stimulation will be performed like in the real arm with the difference that the coil will be masked and thus will be inactive. The patient will hear the same sound of real stimulation, which will be only functionally inactive but will be completely performed (for the whole time of duration of stimulation)

    Device: repetitive transcranial magnetic stimulation

Interventions

  • Devicerepetitive transcranial magnetic stimulation

    Cerebellar repetitive theta Burst stimulation will be performed as detailed in the Real arm description

06

What researchers measure

Primary outcomes

  1. Step variability in dual-task walking

    Step variability will be assessed in normal, cognitive/motor dual-task conditions walking

    Time frame: Changes from Baseline to immediately after stimulation

  2. Step length in dual-task walking

    Step length will be assessed in normal, cognitive/motor dual-task conditions

    Time frame: Changes from Baseline to immediately after stimulation

  3. Gait speed in dual-task walking

    Gait speed will be assessed in normal, cognitive/motor dual-task conditions

    Time frame: Changes from Baseline to immediately after stimulation

Secondary outcomes

  1. Turning speed in timed up and go tests

    Turning will be assessed y wearing sensors during timed up and go tests

    Time frame: Changes from Baseline to immediately after stimulation

  2. total distance of dual-task walking

    The total distance of one minute normal/motor/cognitive dual-task walking will be assessed

    Time frame: Changes from Baseline to immediately after stimulation

07

Study locations

1 of 1 sites recruiting
  • Parkinson's disease Rehabilitation Centre - FERB ONLUS
    Trescore Balneario, Italy
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The whole study will be published in medical journal

Supporting information: Study protocol, Sap, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 23, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04238000
Lead sponsor
Fondazione Europea di Ricerca Biomedica Ferb Onlus
Collaborators
University of Kiel, Università degli Studi di Brescia
Responsible party
Andrea Pilotto (Parkinson's disease Rehabilitation Centre, Fondazione Europea di Ricerca Biomedica Ferb Onlus) — Principal investigator
First posted
Jan 23, 2020
Start date
Jan 1, 2018
Primary completion
Apr 1, 2020 (estimated)
Completion
Jun 1, 2020 (estimated)
Last update
Jan 23, 2020

Study contacts

Andrea Pilotto, MD
Contact
pilottoandreae@gmail.com
00393396245281
Cristina Rizzetti
Contact
rizzetti@hotmail.it
Andrea Pilotto, MD
principal investigator · FERB Onlus

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion